Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Universidade Federal de Pernambuco
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Information provided by (Responsible Party):
Patrícia Érika de Melo Marinho, Universidade Federal de Pernambuco
ClinicalTrials.gov Identifier:
First received: June 18, 2012
Last updated: December 1, 2014
Last verified: December 2014

The whole body vibration offers better treatment adherence among the elderly, minimizing effort and additional stress to the cardiovascular system and skeletal muscles compared to conventional exercise programs.

Hypothesis: Patients with COPD undergoing a training program on the whole body vibration show better performance in the 6MWT and improvement in muscle strength.

Condition Intervention
Chronic Obstructive Pulmonary Disease (COPD)
Other: whole body vibration

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Effects of Whole Body Vibration Training in Chronic Obstructive Pulmonary Disease (COPD) Patients: a Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by Universidade Federal de Pernambuco:

Primary Outcome Measures:
  • Walked distance in 6MWT [ Time Frame: Increase in distance walked at baseline and 3 months ] [ Designated as safety issue: Yes ]
    Change from baseline in distance walked test 6-minute walk test at 3 months.

Secondary Outcome Measures:
  • Respiratory muscle strength [ Time Frame: Change from baseline in respiratory muscle strength at 3 months ] [ Designated as safety issue: Yes ]
    Increase in respiratory muscle strength.

Estimated Enrollment: 21
Study Start Date: February 2012
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: WVB Training Other: whole body vibration
Exercises on the platform will be made in semi-squat position, static. In the first month training will be held for 10 minutes for the exercises on the platform, 30 seconds of vibration of low intensity, interspersed with rest 60 seconds while standing beside the platform. In the second month training will be held for 15 minutes, lasting 60 seconds of vibration and 30 seconds of rest in standing beside the platform. For the first two weeks training will have low intensity and the last two weeks training will have higher vibration. In the third month, training will be held for 20 minutes, 60 seconds of vibration and 30 seconds of rest while standing beside the platform. The intensity of the vibration will be high.
Other Name: Equipment: Power Plate my3

Detailed Description:

In the elderly and in COPD patients weight loss includes sarcopenia, resulting from aging itself or due to disuse or disease states associated with and represents the reduction in muscle mass, leading to decreased strength and endurance, with repercussions on the functional abilities of the same. It reduces the power and muscle strength with aging which represent decreasing to carry out daily physical tasks.

In COPD, exacerbations worsen the loss of muscle mass, affecting the respiratory and peripheral muscles, exercise capacity and survival rates, and in the case of severe malnutrition in advanced cases of the disease, the implications of this state are disability which occur between 10-15% in those with mild obstruction and 25% in moderate to severe obstructive and are associated with worse prognosis.

The whole body vibration could be an efficient combination of training methods for elderly patients and is based on the generation of sinusoidal vibrations offered by a platform, which stimulates the muscle spindles resulting in activation of neurons α engines and develop muscle contractions, presenting itself as an alternative to conventional treatment for muscular endurance as well as improving physical fitness


Ages Eligible for Study:   50 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Smoking history, occupational or environmental exposure to pollutants and / or cough, hypersecretion or dyspnea,
  • FEV1 <80% predicted and postbronchodilator FEV1/FVC <70% to confirm the diagnosis of airway obstruction air not fully reversible bronchodilator therapy,
  • Have the ability to perform the walk test, 6 minutes, absence of comorbidities that preclude the achievement of effort (hypertension, severe pulmonary hypertension, myocardial infarction, congestive heart failure, severe dyspnea)
  • Preserved cognitive functioning,
  • Clinically stable during the study period

Exclusion Criteria:

  • Have cognitive impairment, hearing or visual compromise the response to the questionnaires used in this study
  • Make modifications to the appliance neuro-musculo-skeletal system that prevents the completion of the 6MWT
  • Be participating in physical activity programs.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01649310

Contact: Patricia Marinho Patricia Marinho, PhD 55 81 21268496 patmarinho@yahoo.com.br

Universidade Federal de Pernambuco Recruiting
Recife, Pernambuco, Brazil, 50.740-560
Contact: Patricia EM Marinho, PhD    8191069204    patmarinho@yahoo.com.br   
Principal Investigator: Patricia EM Marinho, PhD         
Sponsors and Collaborators
Universidade Federal de Pernambuco
Conselho Nacional de Desenvolvimento Científico e Tecnológico
  More Information

Additional Information:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Patrícia Érika de Melo Marinho, Professor, Universidade Federal de Pernambuco
ClinicalTrials.gov Identifier: NCT01649310     History of Changes
Other Study ID Numbers: Patricia 
Study First Received: June 18, 2012
Last Updated: December 1, 2014
Health Authority: Brazil: Ethics Committee

Keywords provided by Universidade Federal de Pernambuco:
Chronic obstructive pulmonary disease (COPD)
Muscle strenght

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on February 04, 2016